FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3106768654> ?p ?o ?g. }

• W3106768654 endingPage "001" @default.
• W3106768654 startingPage "PO" @default.
• W3106768654 abstract "Abstract Introduction: Adherence to oral endocrine therapy (OET) reduces recurrence risk for hormone receptor-positive breast cancer (HR+ BC). Refill data accessed through electronic health records (EHRs) may provide objective assessment of medication adherence. Our goal was to (1) determine feasibility of reviewing EHR to assess medication adherence, (2) evaluate 6-month OET adherence in HR+ BC patients, and (3) identify predictors of low adherence. Materials and methods: A single-center, retrospective study from May through December 2018 was conducted. Primary endpoint was adherence rate at 6-months. Chi-square and student’s t-test were used to compare adherent and non-adherent groups. Multivariable logistic regression models were used to assess predictors of adherence. Further, a subgroup analysis was further conducted among patients with stage 0 – III to assess the adherence in early-stage setting. Results: Of 492 patients, 338 patients were included in adherence analysis. Of 338 patients identified, 82% (n= 277) were adherent at 6 months. In the multivariable logistic model, race/ethnicity, type of endocrine therapy, and time on therapy were found to be significantly associated with adherence. Asian/Non-Hispanic and Caucasian/Hispanic patients were less likely to be adherent as compared to Caucasian/Non-Hispanics (Asian/Non-Hispanic OR 0.3; 95% CI 0.11-0.82, Caucasian/Hispanic OR 0.27; 95% CI 0.11-0.64). Patients on aromatase inhibitors were more likely to be adherent as compared to patients on tamoxifen (OR 2.06; 95% CI 1.02-4.14). Lastly, patients on OET for 3-5 years had lower adherence as compared to patients on OET for 2 years or less (OR 0.29; 95% CI 0.09-0.91). The subgroup analysis of patients with stage 0-III disease revealed similar findings that race/ethnicity and type of endocrine therapy were significant predictors of adherence. Conclusion: Accessing refill data through EHR was found to be feasible. Tamoxifen therapy, Asian/Non-Hispanic and Caucasian/Hispanic origin, and longer time on therapy predicted non-adherence in our patients. Citation Format: Anjana Mohan, Rutugandha Paranjpe, Grace Hwang, Carine Opsomer, Kelvin Lu, Uzo Abajue, Hanna Zaghloul, Susan Abughosh, Meghana Trivedi. Evaluating medication adherence and its predictors among breast cancer survivors on oral endocrine therapy in a large academic medical center [abstract]. In: Proceedings of the AACR Virtual Conference: Thirteenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2020 Oct 2-4. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(12 Suppl):Abstract nr PO-001." @default.
• W3106768654 created "2020-12-07" @default.
• W3106768654 creator A5016810413 @default.
• W3106768654 creator A5020036041 @default.
• W3106768654 creator A5022807028 @default.
• W3106768654 creator A5039251903 @default.
• W3106768654 creator A5041208258 @default.
• W3106768654 creator A5044880752 @default.
• W3106768654 creator A5060439847 @default.
• W3106768654 creator A5083105414 @default.
• W3106768654 creator A5084519934 @default.
• W3106768654 date "2020-11-30" @default.
• W3106768654 modified "2023-10-09" @default.
• W3106768654 title "Abstract PO-001: Evaluating medication adherence and its predictors among breast cancer survivors on oral endocrine therapy in a large academic medical center" @default.
• W3106768654 doi "https://doi.org/10.1158/1538-7755.disp20-po-001" @default.
• W3106768654 hasPublicationYear "2020" @default.
• W3106768654 type Work @default.
• W3106768654 sameAs 3106768654 @default.
• W3106768654 citedByCount "0" @default.
• W3106768654 crossrefType "journal-article" @default.
• W3106768654 hasAuthorship W3106768654A5016810413 @default.
• W3106768654 hasAuthorship W3106768654A5020036041 @default.
• W3106768654 hasAuthorship W3106768654A5022807028 @default.
• W3106768654 hasAuthorship W3106768654A5039251903 @default.
• W3106768654 hasAuthorship W3106768654A5041208258 @default.
• W3106768654 hasAuthorship W3106768654A5044880752 @default.
• W3106768654 hasAuthorship W3106768654A5060439847 @default.
• W3106768654 hasAuthorship W3106768654A5083105414 @default.
• W3106768654 hasAuthorship W3106768654A5084519934 @default.
• W3106768654 hasConcept C121608353 @default.
• W3106768654 hasConcept C126322002 @default.
• W3106768654 hasConcept C143998085 @default.
• W3106768654 hasConcept C151956035 @default.
• W3106768654 hasConcept C167135981 @default.
• W3106768654 hasConcept C195910791 @default.
• W3106768654 hasConcept C2426938 @default.
• W3106768654 hasConcept C2777176818 @default.
• W3106768654 hasConcept C3018553135 @default.
• W3106768654 hasConcept C530470458 @default.
• W3106768654 hasConcept C71924100 @default.
• W3106768654 hasConcept C98274493 @default.
• W3106768654 hasConceptScore W3106768654C121608353 @default.
• W3106768654 hasConceptScore W3106768654C126322002 @default.
• W3106768654 hasConceptScore W3106768654C143998085 @default.
• W3106768654 hasConceptScore W3106768654C151956035 @default.
• W3106768654 hasConceptScore W3106768654C167135981 @default.
• W3106768654 hasConceptScore W3106768654C195910791 @default.
• W3106768654 hasConceptScore W3106768654C2426938 @default.
• W3106768654 hasConceptScore W3106768654C2777176818 @default.
• W3106768654 hasConceptScore W3106768654C3018553135 @default.
• W3106768654 hasConceptScore W3106768654C530470458 @default.
• W3106768654 hasConceptScore W3106768654C71924100 @default.
• W3106768654 hasConceptScore W3106768654C98274493 @default.
• W3106768654 hasIssue "12_Supplement" @default.
• W3106768654 hasLocation W31067686541 @default.
• W3106768654 hasOpenAccess W3106768654 @default.
• W3106768654 hasPrimaryLocation W31067686541 @default.
• W3106768654 hasRelatedWork W1968489944 @default.
• W3106768654 hasRelatedWork W2020016788 @default.
• W3106768654 hasRelatedWork W2062795632 @default.
• W3106768654 hasRelatedWork W2111940104 @default.
• W3106768654 hasRelatedWork W2112427223 @default.
• W3106768654 hasRelatedWork W2151206172 @default.
• W3106768654 hasRelatedWork W2327258659 @default.
• W3106768654 hasRelatedWork W4248962432 @default.
• W3106768654 hasRelatedWork W4366694878 @default.
• W3106768654 hasRelatedWork W2183291585 @default.
• W3106768654 hasVolume "29" @default.
• W3106768654 isParatext "false" @default.
• W3106768654 isRetracted "false" @default.
• W3106768654 magId "3106768654" @default.
• W3106768654 workType "article" @default.